Litcius/Paper detail

Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade

Casey Moore, Ching-Cheng Hsu, Wei‐Min Chen, Benjamin P.C. Chen, Chuanhui Han, Michael D. Story, Todd A. Aguilera, Laurentiu M. Pop, Raquibul Hannan, Yang-Xin Fu, Debabrata Saha, Robert Timmerman

2021International Journal of Radiation Oncology*Biology*Physics144 citationsDOIOpen Access PDF

Topics & Concepts

BlockadeImmune checkpointStereotactic radiotherapyMedicineRadiation therapyNeuroscienceRadiosurgeryBiologyInternal medicineReceptorCancer Immunotherapy and BiomarkersCAR-T cell therapy researchRadiopharmaceutical Chemistry and Applications
Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade | Litcius